המוגלובינוריה לילית התקפית
הערות שוליים

1 2 3 4 5 6 7 8 9  Harrison's Principles of Internal Medicine, 19th edition, McGraw-Hill Professional, עמ' 660
1 2 3 4 5 6  Williams Hematology, 9th edition, McGraw-Hill
↑  Charles J. Parker, Paroxysmal nocturnal hemoglobinuria, Current Opinion in Hematology 19, עמ' 141–148 doi: 10.1097/moh.0b013e328351c348
↑  Sophie de Guibert, Régis Peffault de Latour, Nathalie Varoqueaux, Hélène Labussière, Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience, Haematologica 96, 2011-09-01, עמ' 1276–1283 doi: 10.3324/haematol.2010.037531
1 2 3 4  Charles Parker, Mitsuhiro Omine, Stephen Richards, Jun-ichi Nishimura, Diagnosis and management of paroxysmal nocturnal hemoglobinuria, Blood 106, 2005-12-01, עמ' 3699–3709 doi: 10.1182/blood-2005-04-1717
↑  אתר מאגר חולי PNH
1 2 3 4 5 6 7 8 9  Robert A. Brodsky, Paroxysmal nocturnal hemoglobinuria, Blood 124, 2014-10-30, עמ' 2804–2811 doi: 10.1182/blood-2014-02-522128
↑  T Wiedmer, SE Hall, TL Ortel, WH Kane, WF Rosse and PJ Sims, Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria, BLOOD
↑  Russell P. Rother, Leonard Bell, Peter Hillmen, Mark T. Gladwin, The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin, JAMA 293, 2005-04-06 doi: 10.1001/jama.293.13.1653
↑  Peter Hillmen, Modupe Elebute, Richard Kelly, Alvaro Urbano-Ispizua, Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria, American Journal of Hematology 85, 2010-08-01, עמ' 553–559 doi: 10.1002/ajh.21757
↑  Anita Hill, Robert J. Sapsford, Andrew Scally, Richard Kelly, Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function, British Journal of Haematology 158, 2012-08-01, עמ' 409–414 doi: 10.1111/j.1365-2141.2012.09166.x
↑  M Bessler, P J Mason, P Hillmen, T Miyata, Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene., The EMBO Journal 13, 1994-01-01, עמ' 110–117
↑  David J. Araten, Khedoudja Nafa, Kriangsak Pakdeesuwan, Lucio Luzzatto, Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals, Proceedings of the National Academy of Sciences 96, 1999-04-27, עמ' 5209–5214 doi: 10.1073/pnas.96.9.5209
↑  Rong Hu, Galina L. Mukhina, Steven Piantadosi, Jamie P. Barber, PIG-A mutations in normal hematopoiesis, Blood 105, 2005-05-15, עמ' 3848–3854 doi: 10.1182/blood-2004-04-1472
↑  S. B. ONI, B. O. OSUNKOYA and L. LUZZATTO, Paroxysmal Nocturnal Hemoglobinuria: Evidence for Monoclonal Origin of Abnormal Red Cells, BLOOD
↑  The Leucocyte Antigen Factsbook, San Diego : Academic Press, 1997
↑  Robert A Brodsky, MD, Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria
1 2  Robert A Brodsky, MD, Treatment and prognosis of paroxysmal nocturnal hemoglobinuria
↑  היסטוריית האישורים של אקוליזומב
1 2 3 4  Robert A Brodsky, MD, Treatment and prognosis of paroxysmal nocturnal hemoglobinuria
↑  McKeage K., Eculizumab: A Review of its Use in Paroxysmal Nocturnal Haemoglobinuria, 2011
↑  Peter Hillmen, Petra Muus, Ulrich Dührsen, Antonio M. Risitano, Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria, Blood 110, 2007-12-01, עמ' 4123–4128 doi: 10.1182/blood-2007-06-095646
↑  Peter Hillmen, Neal S. Young, Jörg Schubert, Robert A. Brodsky, The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria, New England Journal of Medicine 355, 2006-09-21, עמ' 1233–1243 doi: 10.1056/nejmoa061648
↑  מידע על אקוליזומב באתר מנהל המזון והתרופות האמריקני
↑  Allen O. Applegate, Vanessa C. Fong, Kara Tardivel, Susan A. Lippold, Notes from the Field: Meningococcal Disease in an International Traveler on Eculizumab Therapy — United States, 2015, MMWR. Morbidity and Mortality Weekly Report 65, 2016, עמ' 696–697 doi: 10.15585/mmwr.mm6527a3
↑  מידע על אקוליזומב באתר סל התרופות
| --- | --- |
בקרת זהויות :  NLI: 987007537356905171  BnF: cb12451791g (data)  LCCN: sh99004283 
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.
החלבון CD55
החלבון CD59